Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in Florida

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe medications through telemedicine — or trying to navigate the maze of state-by-state prescribing rules — you’re not alone. Telepsychiatry has exploded over the past few years, and while the clinical care translates beautifully to video visits, the regulatory landscape remains confusing.

The short answer: Yes, psychiatrists can prescribe nearly all psychiatric medications via telehealth in 2026, including controlled substances like stimulants and benzodiazepines. But the details matter — especially if you’re a PMHNP, practicing across state lines, or trying to understand what your state allows.

This guide cuts through the confusion. We’ll cover what psychiatrists and PMHNPs can prescribe via telehealth, how federal and state rules interact, what the differences are between MD and NP prescribing authority, and what reimbursement looks like for medication management. Whether you’re in California, Texas, Florida, New York, Pennsylvania, or Illinois, we’ll break down the rules that affect your practice.

What Psychiatrists Can Prescribe via Telehealth (Federal and State Rules)

Federal Framework: The DEA Waiver and Ryan Haight Act

Federally, prescribing controlled substances (Schedule II–V medications like Adderall, Xanax, or Suboxone) via telemedicine was historically restricted by the Ryan Haight Act, which required at least one in-person exam before a provider could prescribe controlled substances to a new patient.

That changed during COVID-19. The DEA issued emergency waivers allowing controlled substance prescriptions via telehealth without an initial in-person visit. As of early 2026, those flexibilities remain in effect through December 31, 2025 and are expected to be extended further while the DEA finalizes permanent rules.

What this means for psychiatrists:

• You can evaluate a new patient via video visit and prescribe stimulants for ADHD, benzodiazepines for anxiety, or buprenorphine for opioid use disorder — all without seeing them in person first.
• You must still maintain the same standard of care: a thorough evaluation via secure audio-video technology, appropriate documentation, and clinical justification for prescribing.
• Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances — this is required in nearly every state, including all six of our priority states.

The DEA has proposed new rules that may eventually require special telemedicine registrations or impose limits (like 30-day supplies for initial prescriptions), but those haven’t been finalized. For now, telepsychiatry providers have broad authority under the temporary federal waiver.

State-Level Telehealth Prescribing: Key Variations

While federal law sets the baseline, state laws can add restrictions — or, in some cases, explicitly permit what federal law allows. Here’s how it breaks down in our priority states:

Florida: One of the most permissive states for psychiatric telehealth prescribing. Florida law explicitly allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders (Florida Statutes §456.47). The only exception is chronic pain management (which requires in-person exams). This carve-out means a Florida-licensed psychiatrist can start a patient on ADHD stimulants or anti-anxiety medications entirely via telemedicine — a huge advantage for access.

Texas: Texas law allows telemedicine prescribing if the standard of care is met, but prohibits prescribing opioids for chronic pain via telehealth. For psychiatric treatment, though, you’re in the clear: Texas permits tele-prescribing of controlled substances for mental health conditions like ADHD or acute anxiety, as long as it’s done through a valid audio-video encounter and complies with federal law. Texas also requires checking the state’s Prescription Monitoring Program before prescribing any controlled substance.

New York: New York recently updated its rules (finalized in mid-2025) to align with federal telehealth allowances. The state now explicitly permits controlled substance prescribing via telehealth when consistent with federal DEA waivers. Prior to this change, NY technically required an in-person exam for controlled substances (though emergency orders had suspended that requirement). Now, NY psychiatrists can confidently initiate controlled medications via telehealth under the federal waiver, with no additional state obstacles.

California: California has long required a ‘good faith exam’ before prescribing, but the state recognizes that a telehealth exam satisfies this requirement. California law does not mandate in-person visits for prescribing; a thorough video evaluation is sufficient. During the federal telehealth waiver period, CA psychiatrists have been prescribing stimulants and other controlled meds to new patients via telemedicine. California does require enrollment in CURES (the state’s PDMP) and checking it before prescribing Schedule II–IV drugs.

Pennsylvania: Pennsylvania has no unique state-level telehealth prescribing restrictions beyond federal law. Psychiatrists follow the DEA’s rules, and during the current waiver period, they can prescribe controlled substances via telehealth. PA does not have a comprehensive telehealth parity statute yet, but Medicaid and major insurers cover telepsychiatry services.

Illinois: Illinois generally allows prescribing via telehealth if the standard of care is met. The state defers to federal law on controlled substances, so Illinois psychiatrists can prescribe under the DEA waiver. Illinois also has strong telehealth parity laws requiring private insurers to reimburse telehealth services at the same rate as in-person through at least 2027 for behavioral health.

Establishing a Valid Patient Relationship

All states require a legitimate clinical relationship before prescribing. For telehealth, this means conducting a real-time audio-visual consultation that allows for the same level of assessment as an in-person visit. States like Texas and California explicitly define a valid telemedicine encounter as one with interactive video communication (not just a phone call or questionnaire).

Best practices:

• Use a HIPAA-compliant video platform
• Verify the patient’s identity and location (important for licensure compliance — you must be licensed in the state where the patient is physically located)
• Document the visit thoroughly, including that it was conducted via telehealth
• Obtain informed consent for telehealth services (some states like Texas and California require this)
• Have an emergency protocol if the patient is in crisis (many state medical boards require this for telehealth providers)

What About Audio-Only Visits?

During the pandemic, Medicare and some states began allowing audio-only (telephone) visits for mental health services, recognizing the digital divide. As of 2026, Medicare still permits certain mental health services delivered via phone to be reimbursed at the same rate as video visits, as long as the patient cannot use video. States like Massachusetts and Illinois also require coverage of audio-only mental health visits.

However, for prescribing controlled substances, best practice is to use video for initial evaluations. Follow-up medication checks for established patients may sometimes be done via phone in states that allow it, but the DEA’s proposed rules may eventually require video for controlled substance prescribing. Until those rules are finalized, use clinical judgment and follow your state’s telehealth standards.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

PMHNP vs. Psychiatrist Prescribing Authority: What’s the Difference?

This is where things get complicated. Psychiatrists (MD/DO) have full, independent prescribing authority in every state. PMHNPs’ authority, however, varies dramatically by state.

Psychiatrists: Full Independent Authority

If you’re a psychiatrist, your prescribing authority is straightforward:

• No supervision or collaboration required in any state
• Full formulary access — you can prescribe any medication within your scope of practice, including all controlled substances
• Same telehealth rules apply as in-person (follow federal DEA waivers and state telehealth laws)
• DEA registration required for controlled substances (federal requirement, same for all prescribers)

The only limitations psychiatrists face are general medical regulations (e.g., special REMS training for clozapine, or formerly the X-waiver for buprenorphine, which was eliminated in 2023).

PMHNPs: It Depends on Your State

Psychiatric nurse practitioners operate under state nursing board authority, and their scope of practice varies by state. As of 2025, states fall into three categories:

1. Full Practice Authority (FPA) States
In these states, PMHNPs can practice independently — no physician collaboration or supervision required. They can:

• Evaluate, diagnose, and treat patients on their own
• Prescribe medications (including Schedule II–V controlled substances) under their own DEA registration
• Open their own practices without a physician partner

Approximately 34 states now grant full practice authority to experienced NPs. Recent additions include Massachusetts (2021), Kansas (2022), Indiana (2023), Louisiana (2024), and Michigan (2025).

However, some FPA states have transition periods. For example:

• New York: New PMHNPs must practice under a collaborative agreement for their first 3,600 hours (~2 years full-time). After that, they practice independently with only an informal ‘collaborative relationship’ (consultative ties, no supervision required).
• Illinois: NPs must complete 4,000 hours of practice under physician collaboration plus 250 hours of continuing education before they can apply for Full Practice Authority licensure.
• California: Through AB 890 (2020), NPs with ≥3 years of experience can become ‘103 NPs’ to practice in group settings without direct supervision (effective 2023). By January 1, 2026, those NPs can become ‘104 NPs’ with full independent practice authority, even solo. New graduates still need physician-supervised standardized procedures for at least 3 years.

2. Reduced Practice States
These states require PMHNPs to have a collaborative practice agreement with a physician for prescribing, but the NP has some independence in practice. The physician isn’t required to be on-site, but there must be a written agreement, periodic chart reviews, and physician availability for consultation.

Pennsylvania is a classic example. PA requires:

• A written collaborative agreement with a physician (often a psychiatrist for psychiatric NPs)
• The agreement must detail which medications the NP can prescribe
• Physician must review a portion of the NP’s charts periodically (often 10% quarterly)
• For Schedule II prescriptions, physician must be notified within 24 hours
• No pathway to independence — collaboration required indefinitely

There is no Full Practice Authority pathway in PA yet, though legislation has been proposed.

3. Restricted Practice States
In these states, PMHNPs must practice under continuous physician supervision for all patient care activities. Prescribing is only allowed through explicit physician delegation.

Texas is the most restrictive among our priority states:

• All NP practice is considered delegated from a physician — PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe any medication
• The physician must meet with the NP monthly for the first 3 years, then quarterly thereafter
• Physician can supervise no more than 7 NPs/PAs at once
• Schedule II controlled substances generally cannot be prescribed by NPs in outpatient settings (limited exceptions for terminal illness or children with ADHD under narrow conditions)
• No pathway to independence — all Texas NPs require physician oversight indefinitely

Florida is also restrictive for psychiatric NPs, despite recent reforms:

• Florida’s 2020 law (HB 607) created ‘Autonomous APRN’ status for primary care NPs only (family medicine, internal medicine, pediatrics) — psychiatric NPs were excluded
• PMHNPs must practice under a supervising physician’s protocol
• They can prescribe controlled substances, but Schedule II prescriptions are capped at 7 days for most NPs — except ‘psychiatric nurses’ treating mental illness (who can prescribe longer courses of psychotropic meds)
• Florida defines ‘psychiatric nurse’ as a PMHNP with ≥2 years of experience under a psychiatrist, who can then prescribe psychotropic controlled substances in collaboration with a psychiatrist
• Bills to extend autonomous practice to psychiatric NPs (like HB 771 in 2024) have been proposed but not yet passed

Collaborative Agreement Requirements: What Do They Actually Entail?

In states requiring collaboration, the specifics matter. A typical collaborative practice agreement (CPA) includes:

Scope of Practice: What conditions the NP can diagnose and treat, which medications they can prescribe (some agreements exclude certain drug classes or populations, like Schedule II for pediatrics)

Physician Availability: The collaborating physician must be available for consultation (usually by phone), with defined response times

Chart Review: Many states require the physician to sample a percentage of the NP’s charts regularly (e.g., South Carolina requires 10% monthly, Texas requires periodic quality assurance meetings)

Meetings: Some states mandate regular face-to-face or virtual meetings between the NP and physician (Texas requires monthly for first 3 years, then quarterly)

State Filing: Some states require the CPA to be filed with the state nursing or medical board (e.g., Kentucky requires filing a ‘CAPA-CS’ for controlled substance authority)

Specialty Match: Some states require the collaborating physician to be in the same specialty. For example:

• Florida requires psychiatric NPs to collaborate with a psychiatrist to prescribe psychotropic controlled substances
• Pennsylvania’s rules suggest the collaborating physician should have relevant expertise in the NP’s specialty

Ratios: Some states limit how many NPs a single physician can supervise. Texas caps it at 7 NPs/PAs per physician.

Reimbursement Differences

Even when PMHNPs have similar legal authority to psychiatrists, reimbursement can differ:

• Medicare reimburses nurse practitioner services at 85% of the physician fee schedule when billed under the NP’s own NPI
• Many private insurers follow a similar model, paying NPs 85–90% of physician rates
• Some states have passed equal reimbursement laws (Nevada, Maryland) mandating insurers pay NPs the same as MDs for the same service
• In practice, some clinics have NP services billed ‘incident to’ a supervising physician to capture 100% reimbursement — but this cannot be done for telehealth under current Medicare rules (no incident-to billing for telemedicine)

From a practice economics standpoint: an MD generates 100% of the fee schedule per visit, an NP might generate 85%. This is one reason telehealth companies carefully structure provider mix and billing.

Medication Management Reimbursement for Psychiatrists: What You’ll Actually Get Paid

Understanding reimbursement is critical for practice sustainability. Here’s what psychiatric medication management pays in 2026:

Common Billing Codes

Initial Evaluation:

• CPT 90792 (Psychiatric Diagnostic Evaluation with Medical Services) — 60-minute initial consult
• Medicare 2026 rate: ~$173 national average

Follow-Up Medication Management:

• 99213 (15-minute follow-up, established patient, moderate complexity)
• Medicare 2026: ~$95
• 99214 (25-minute follow-up or higher complexity)
• Medicare 2026: ~$136
• 99215 (40-minute follow-up, very complex)
• Medicare 2026: ~$192 (rarely used for routine med checks)

Psychotherapy Add-Ons (if combining therapy with med management):

• 90833 (30-minute psychotherapy add-on): ~$80
• 90838 (60-minute psychotherapy add-on): ~$135

These codes can be billed for telehealth visits at the same rate as in-person (use POS-02 or modifier -95 for Medicare; private payers vary).

NP Reimbursement

PMHNPs billing under their own NPI receive 85% of the above rates for Medicare patients. For example:

• 99213 for an NP: ~$81 (vs $95 for MD)
• 99214 for an NP: ~$116 (vs $136 for MD)

Some private payers credential NPs separately and may pay 85–100% of physician rates depending on contract negotiations.

Private Insurance

Commercial insurance typically pays more than Medicare, but rates vary widely by region and insurer. In high cost-of-living areas, a major insurer might pay:

• $150 for 99213 (vs Medicare’s $95)
• $200 for 99214 (vs Medicare’s $136)

Telehealth Parity Laws

Over 40 states now have laws requiring private insurers to cover telehealth at parity with in-person for behavioral health. Key examples:

• Illinois: SB 667 (2021) mandates equal reimbursement for telehealth through at least 2027
• California: AB 744 (2019) requires payment parity for telehealth contracts after 2021
• New York: Updated law in 2021 ensures telehealth reimbursement (rates negotiable but generally equal)
• Texas: Has telehealth coverage requirements but does not mandate payment parity — however, many insurers voluntarily pay equal rates for tele-mental health due to high demand

Medicaid Reimbursement

Medicaid rates are typically lower than Medicare, but many states have behavioral health enhancements:

• Florida Medicaid: ~$60–80 for a 15-minute med check
• California Medi-Cal: Historically ~75% of Medicare rates, though recent investments aim to increase behavioral health reimbursement
• New York Medicaid: Reimburses tele-mental health at the same rate as in-person
• Pennsylvania Medicaid: Expanded telehealth coverage permanently, pays same for psychiatric med reviews via telehealth

Audio-Only Visits

Medicare now pays for audio-only mental health services at the same rate as video visits (as of 2022), as long as the patient cannot use video. This flexibility has been extended through 2024 and applies to psychiatric medication management phone check-ins. States like Massachusetts and Illinois also require coverage of audio-only mental health visits.

Other Reimbursement Streams

Collaborative Care Model (CoCM): Psychiatrists serving as consultants to primary care teams can bill:

• 99492 (first month): ~$161
• 99493 (subsequent months): ~$130

Medicare and some Medicaid programs (NY, WA) reimburse these codes.

Key Takeaways on Reimbursement

• Strong parity for telehealth in mental health — Medicare and most private payers pay the same for video visits as in-person
• Medicare’s 2026 rates are stable with modest inflation adjustments
• Private insurance often pays 50–100% more than Medicare, depending on market
• NPs receive 85% of physician rates for Medicare (and similar reductions from many private payers)
• Document appropriately — coding is based on medical decision-making or time; under-documenting costs you money
• Telehealth has reduced no-show rates in many practices, improving overall revenue

State-by-State Breakdown: California, Texas, Florida, New York, Pennsylvania, Illinois

Here’s how prescribing authority, telehealth rules, and practice requirements differ across our priority states:

California

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Transitioning to independence via AB 890 (2020):

• NPs with ≥3 years experience can become ‘103 NPs’ (effective Jan 2023) to practice in group settings without physician supervision
• By Jan 1, 2026, experienced NPs can become ‘104 NPs’ with full independent practice authority, including solo practice
• New graduates must work under physician-supervised standardized procedures for ≥3 years first

Telehealth: CA permits prescribing via telemedicine with a ‘good faith exam’ (video qualifies). No in-person requirement. Must check CURES (state PDMP) before prescribing Schedule II–IV drugs.

Controlled Substances: Can be prescribed via telehealth under federal DEA waiver. CA defers to federal law.

Reimbursement: AB 744 requires private payer telehealth parity. Strong coverage for tele-mental health.

Workforce: High demand — over 11 million Californians live in Mental Health Professional Shortage Areas. Psychiatrist-to-population ratio ~1:5,000 (better than TX/FL but still significant gaps).

Texas

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Restricted practice — must have Prescriptive Authority Agreement with a Texas physician for all prescribing. No pathway to independence.

• Physician must meet with NP monthly for first 3 years, then quarterly
• Physician can supervise maximum 7 NPs/PAs
• Schedule II controlled substances generally cannot be prescribed by NPs in outpatient settings (limited exceptions)
• Schedule III–V allowed with physician delegation

Telehealth: Texas allows telemedicine prescribing if standard of care met. Prohibits telehealth Rx of Schedule II for chronic pain (must see in person). Mental health treatment via telehealth is allowed — no special prohibition on stimulants via tele if federal law allows.

Controlled Substances: Must check Texas PMP before prescribing. Texas mirrors federal rules for psychiatric controlled substances via telehealth.

Reimbursement: Texas has telehealth coverage law but no mandated payment parity. Many insurers voluntarily pay equal rates for tele-mental health.

Workforce: Severe shortage — psychiatrist-to-population ratio ~1:8,500. Texas has 380 mental health HPSAs needing 614 psychiatrists.

Florida

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Restricted for psychiatric specialty:

• Florida’s 2020 ‘Autonomous APRN’ law applies only to primary care NPs (family, pediatrics, internal medicine) — psychiatric NPs excluded
• PMHNPs must practice under supervising physician’s protocol
• Can prescribe controlled substances, but Schedule II capped at 7 days for most NPs — except ‘psychiatric nurses’ treating mental illness (can prescribe longer courses)
• ‘Psychiatric nurse’ defined as PMHNP with ≥2 years experience under a psychiatrist
• Must collaborate with a psychiatrist to prescribe psychotropic controlled substances

Telehealth: Florida law explicitly allows teleprescribing of controlled substances for psychiatric treatment (FS §456.47) — a major exception. Out-of-state providers can register for telehealth, but out-of-state NPs cannot prescribe controlled substances under that registration.

Controlled Substances: Very permissive for psychiatric telehealth prescribing (MDs and qualified psychiatric NPs).

Reimbursement: No state parity mandate, but many insurers voluntarily cover tele-mental health at parity.

Workforce: Severe shortage — psychiatrist-to-population ratio ~1:9,000. Approximately 7.8 million Floridians in mental health shortage areas.

New York

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Reduced practice transitioning to FPA:

• New NPs must practice under collaborative agreement for first 3,600 hours (~2 years full-time)
• After 3,600 hours, can practice independently without written agreement or supervision (just informal ‘collaborative relationship’ for referrals)
• No chart review or co-signing required for experienced NPs

Telehealth: NY updated rules in mid-2025 to explicitly permit controlled substance prescribing via telehealth when consistent with federal DEA waivers. Previously required in-person exam but emergency orders suspended that; now permanently aligned with federal allowances.

Controlled Substances: Must check NY’s I-STOP PMP registry before prescribing Schedule II–IV. E-prescribing required (no paper scripts for controlled meds since 2016).

Reimbursement: Strong telehealth support — all insurers must cover. Private payer parity generally in place.

Workforce: High concentration of psychiatrists in NYC (~1:2,900 statewide), but upstate regions undersupplied. NY has ~197 mental health HPSAs needing ~230 psychiatrists.

Pennsylvania

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Reduced practice (no FPA pathway yet):

• Must have collaborative agreement with physician indefinitely (no experience-based independence)
• Agreement must detail NP’s scope and prescribing authority
• Can prescribe Schedule II–V if delegated, but Schedule II limited to 30-day supply and physician must be notified within 24 hours
• Physician must review portion of NP’s charts regularly (often 10% quarterly)

Telehealth: PA has no unique state-level telehealth prescribing restrictions beyond federal law. Follows DEA waiver for controlled substances.

Controlled Substances: Can be prescribed via telehealth under federal waiver.

Reimbursement: PA Medicaid covers telepsychiatry at same rate as in-person. No comprehensive private payer parity statute yet (efforts ongoing).

Workforce: Psychiatrist-to-population ratio ~1:4,600. Rural central PA has significant gaps — state needs ~65 additional psychiatrists to eliminate HPSAs.

Illinois

Psychiatrists: Full independent prescribing. No restrictions.

PMHNPs: Reduced practice with pathway to FPA:

• Must complete 4,000 hours of practice under physician collaboration + 250 hours of CE in advanced pharmacology
• After meeting requirements, can apply for Full Practice Authority license from state board
• Until FPA granted, NP prescriptions must list collaborating physician’s name (delegated authority)
• With FPA, can prescribe independently including Schedule II–V (must apply for mid-level controlled substance license)

Telehealth: Illinois has strong telehealth parity — SB 667 (2021) mandates equal reimbursement for telehealth through 2027 for behavioral health.

Controlled Substances: NPs with FPA can prescribe II–V independently. Without FPA, Schedule II limited to 30 days in consultation with physician.

Reimbursement: Excellent telehealth coverage and parity. Illinois Medicaid and commercial plans pay equally for tele vs in-person mental health.

Workforce: Psychiatrist-to-population ratio ~1:5,800. State needs ~291 additional practitioners to eliminate mental health shortages.

Unique: Illinois allows licensed Clinical Psychologists with specialized training to prescribe limited formulary of mental health meds under psychiatrist supervision — adds to prescriber capacity.

Practice Economics: What Does Patient Acquisition Actually Cost?

Let’s talk real numbers. One of the biggest misconceptions in telehealth marketing is that you can acquire psychiatric patients cheaply through DIY marketing. The reality is far different.

The True Cost of DIY Patient Acquisition

SEO (Search Engine Optimization):

• Takes 6–12 months of consistent investment before generating meaningful patient flow
• Requires expert content creation, technical optimization, and ongoing maintenance
• Most solo providers don’t have the expertise or patience to execute effectively
• Even when successful, you’re competing with every other provider in your state who’s doing the same thing

Google Ads:

• Mental health keywords are expensive: $15–40+ per click
• Most clicks don’t convert to booked patients
• Realistic cost per booked patient through PPC: $200–400+
• Requires constant testing, optimization, and budget to stay competitive

Directory Listings:

• Psychology Today, Zocdoc, etc., charge monthly fees AND you compete with hundreds of other providers on the same page
• Zocdoc charges $35–100+ per booking plus subscription fees
• Total monthly cost including subscriptions adds up quickly

When you factor in ALL costs:

• Agency/consultant fees
• Ad spend testing and optimization
• Staff time to handle and qualify leads
• No-show rates from cold leads
• Months of investment before results
• Failed campaigns and wasted spend

Realistic all-in cost to acquire a qualified psychiatric patient through DIY marketing: $200–500+

And that’s assuming you have:

• The marketing budget to sustain months of testing
• The expertise to execute across multiple channels
• The time to manage campaigns while seeing patients
• The patience to wait 6–12 months for SEO to pay off

The Platform Model: Pay Only for Results

This is where Klarity Health’s model makes economic sense. Instead of:

• Spending $3,000–5,000/month on marketing with uncertain results
• Gambling on which channels will work
• Waiting months to see if your investment pays off

You pay a standard listing fee per new patient lead — only when a qualified patient books with you.

The value proposition:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Compare the economics:

• DIY marketing: $3,000–5,000/month with uncertain ROI, takes 6–12 months to see results
• Platform model: $0 upfront, pay only per booked patient, immediate patient flow

The platform removes all acquisition risk. You’re not gambling on marketing channels — you’re paying for guaranteed qualified leads.

This is especially valuable for:

• New providers without established referral networks
• Providers scaling into new states where they have no brand presence
• Anyone who’d rather spend their time seeing patients than managing marketing campaigns

FAQ: Telepsychiatry Prescribing Questions Answered

Can psychiatrists prescribe controlled substances via telehealth in 2026?

Yes. Under the current federal DEA waiver (extended through December 31, 2025 and expected to be extended further), psychiatrists can prescribe Schedule II–V controlled substances to new patients via telehealth without an initial in-person exam. This includes stimulants for ADHD, benzodiazepines for anxiety, and buprenorphine for opioid use disorder. You must conduct a thorough audio-visual evaluation and check your state’s prescription monitoring program.

Do I need to see a patient in person before prescribing via telehealth?

Not currently, due to the federal DEA waiver. However, this could change if/when the DEA finalizes permanent rules. Some states may have additional requirements — for example, Medicare has proposed (but not yet implemented) requiring at least one in-person visit every 6–12 months for patients receiving tele-mental health services. Check both federal DEA updates and your state’s telehealth laws for current requirements.

Can PMHNPs prescribe the same medications as psychiatrists?

It depends on your state. In Full Practice Authority states (like Washington, Oregon, Arizona, Colorado, Minnesota, and — after transition periods — New York, Illinois, and California), experienced PMHNPs can prescribe independently, including Schedule II–V controlled substances. In restricted states (like Texas and Florida), PMHNPs must practice under physician supervision and may have limitations on what they can prescribe (e.g., Texas NPs generally cannot prescribe Schedule II in outpatient settings; Florida caps Schedule II at 7 days unless the NP is a qualified ‘psychiatric nurse’ treating mental illness).

Do I need different state licenses to prescribe via telehealth to patients in multiple states?

Yes. You must be licensed in the state where the patient is physically located at the time of the telehealth visit. The Interstate Medical Licensure Compact (IMLC) helps expedite obtaining multiple state licenses — Texas, Pennsylvania, and Illinois are members. New York, Florida, and California are not in the IMLC, so you’ll need to go through the traditional licensing process for those states. Once licensed, you can prescribe to patients in that state via telehealth under the same rules as local physicians.

What’s the difference in reimbursement between telehealth and in-person visits?

For mental health services, there’s essentially no difference in most states. Medicare pays the same rate for telehealth psychiatric visits as in-person (and has permanently allowed telehealth for mental health with modest requirements). Over 40 states have telehealth parity laws requiring private insurers to reimburse behavioral health telehealth at the same rate as in-person. Some states (like Texas) don’t mandate parity, but most insurers voluntarily pay equal rates due to high demand for tele-mental health.

Can I do medication management follow-ups over the phone, or does it have to be video?

It depends. For established patients on stable medication regimens, some states and payers allow audio-only (telephone) follow-ups. Medicare permits audio-only mental health services if the patient cannot access video. However, for prescribing controlled substances, best practice is to use video, especially for initial evaluations and any significant medication changes. The DEA’s proposed permanent rules may eventually require video for controlled substance prescribing. Check your state’s telehealth standards and payer requirements.

What documentation do I need for telehealth visits where I prescribe medications?

Document the same information as an in-person visit: chief complaint, history of present illness, psychiatric review of systems, mental status exam, assessment, and plan (including medications prescribed and dosages). Additionally, document:

• That the visit was conducted via telehealth (and note the platform/technology used)
• The patient’s location at time of service
• That you verified the patient’s identity
• That you obtained informed consent for telehealth
• That you checked the state prescription monitoring program (for controlled substances)
• Your emergency protocol if the patient is in crisis

Many states require telehealth-specific consent and location documentation, so include these elements in your note template.

How much can I earn doing telepsychiatry medication management?

Medicare pays approximately **

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship